QDPR Antibodies

Santa Cruz Biotechnology features a diverse variety of QDPR monoclonal antibodies for investigating quinonoid dihydropteridine reductase (QDPR) protein function and regulation. QDPR monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). QDPR protein plays a crucial role in the metabolism of tetrahydrobiopterin, a cofactor essential for the synthesis of neurotransmitters such as dopamine and serotonin. Deficiencies in QDPR can lead to hyperphenylalaninemia and other neurological disorders, highlighting its significance in both metabolic pathways and neurological health. Understanding QDPR function is vital for developing therapeutic strategies for related conditions. QDPR monoclonal antibodies enable precise detection and analysis of QDPR expression patterns across various tissues and experimental conditions. Researchers can utilize QDPR monoclonal antibodies to explore cellular localization, protein interactions, and expression levels in different physiological states. QDPR monoclonal antibodies from Santa Cruz Biotechnology support the scientific community in advancing our understanding of neurological disorders and metabolic diseases.